1. Home
  2. BHC

as 12-20-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: QUEBEC
Market Cap: 3.0B IPO Year: N/A
Target Price: $7.25 AVG Volume (30 days): 1.4M
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.48 EPS Growth: N/A
52 Week Low/High: $3.96 - $11.46 Next Earning Date: 10-30-2024
Revenue: $9,474,000,000 Revenue Growth: 10.91%
Revenue Growth (this year): 10.68% Revenue Growth (next year): 3.66%

BHC Daily Stock ML Predictions

Stock Insider Trading Activity of Bausch Health Companies Inc. (BHC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Carson Seana BHC EVP, General Counsel Nov 29 '24 Sell $8.35 440 $3,674.00 433,066

Share on Social Networks: